Asian Spectator

Men's Weekly

.

Menarini Group's Elacestrant Marketing Authorization Applicati...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
FLORENCE, Italy and NEW YORK, Aug. 19, 2022 / PRNewswire-AsiaNet/ -- - Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from second-line (2L) and third-line (3L) ER+/HER2- advanced or metastatic breast cancer in the European Union...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Kenapa nilai zakat Indonesia masih rendah meski pembayaran zakat digital sudah di mana-mana?

● Potensi zakat nasional tembus ratusan triliun.● Dana sebesar itu bisa jadi dana segar pembangunan dan pengentasan kemiskinan nasional.● Pembayaran online ternyata tak mendongkrak p...

‘Lebaran blues’ dan rasa kehilangan: Bagaimana momen hari raya bisa memicu duka

Tampak belakang seorang perempuan mengenakan pakaian salat duduk di kursi roda pada perayaan Idulfitri.Creativa Images/Shutterstock● Bagi mereka yang sedang berduka, hari raya dapat membuat rasa...

The silver lining in Europe’s deforestation law delay: A chance to build fairer supply chains

When you reach for a “palm-oil-free” label at the supermarket, you likely feel you’re doing your part to save orangutans and protect biodiversity. However, the reality behind that la...